Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO (PreloaDren)

July 6, 2010 updated by: Hospital Universitario La Paz

The purpose of this study is

  • To assess the value of dynamics (SVV, PPV) and static indices (GEDVI, ITBVI, CVP) of preload and its combination with contractility (CI,SV, ventricular power, dP/dtmax, CFI, GEF) and lung water indices (ELWI), as predictors of fluid responsiveness in both spontaneously breathing and mechanically ventilated pediatric patients.
  • To assess the value of stroke volume and pulse pressure changes from femoral pulse contour analysis (PiCCO2) during passive leg raising as predictor of fluid responsiveness in pediatric patients.
  • To establish normal and cutoff values of transpulmonary thermodilution (PiCCO2) hemodynamic variables in hemodynamically stables and hemodynamically "normal" patients.

Study Overview

Detailed Description

One of the ongoing challenges in critical care has been determining adequate fluid resuscitation. Overly aggressive volume expansion may produce deleterious effects, especially in patients with respiratory, renal and/or cardiac failure. Since the clinical ability to judge hemodynamic parameters is known to be poor, the determination of variables that would predict response to fluid challenge would be important for clinical decision-making.

Traditional measures of preload (CVP, PAOP) are now known to be incapable to assess the volume status and fluid responsiveness, especially in children.

There are two kinds of reasons for explaining the failure of markers of preload to predict volume responsiveness: the first reason is that the markers commonly used at the bedside are not always accurate measures of cardiac preload; the second reason is that an assessment of preload is not an assessment of preload responsiveness.

The rapid determination of hemodynamic status offered by noninvasive hemodynamic devices as PICCO2 would allow tailoring of volume expansion necessary in hypoperfusion states to increase left ventricular volume and cardiac output. Studies in critically ill adults patients have demonstrated that passive leg raising autotransfusion and functional hemodynamic monitoring, by using pulse contour analysis, are reliable in the detection of fluid responsiveness. However, currently we have very few studies in pediatric patients using arterial pulse contour analysis and transpulmonary thermodilution, which does not allow the rational application of the hemodynamic variables for guiding fluid resuscitation.

This study pretend to assess 1) the value of dynamics and static indices of preload, and its combination with contractility and lung water indices, as predictors of fluid responsiveness in both spontaneously breathing and mechanically ventilated pediatric patients and 2) the value of stroke volume and pulse pressure changes during passive leg raising autotransfusion, as predictors of fluid responsiveness in pediatric patients.

In this observational study, the hemodynamical variables are registered during the hemodynamically unstable, stable and "normal" states of the pediatric patient and before and after clinically indicated fluid (crystalloid, colloid or hemoderivative) infusion. Passive leg raising hemodynamic changes will be compared with the hemodynamic changes caused by fluid infusion.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cordoba, Spain, 14004
        • Recruiting
        • Hospital Universitario Reina Sofia
        • Contact:
        • Principal Investigator:
          • Susana Jaraba-Caballero, MD
      • Madrid, Spain, 28034
        • Recruiting
        • Hospital Universitario Ramon y Cajal
        • Contact:
        • Principal Investigator:
          • Maria Elena Alvarez-Rojas, MD
      • Madrid, Spain, 28041
        • Recruiting
        • Hospital Universitario 12 de Octubre
        • Contact:
        • Principal Investigator:
          • Ignacio Sanchez-Diaz, MD PhD
        • Sub-Investigator:
          • Silvia Belda-Hofheinz, MD
      • Madrid, Spain, 28009
        • Recruiting
        • Hospital Infantil Universitario del Niño Jesús
        • Contact:
        • Principal Investigator:
          • Ana Serrano, MD PhD
        • Sub-Investigator:
          • Maria Isabel Iglesias-Bouzas, MD
      • Madrid, Spain, 28223
        • Recruiting
        • Hospital Universitario La Paz
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Juan Jose Menéndez-Suso, MD
      • Malaga, Spain, 29010
        • Recruiting
        • Hospital Regional Universitario Carlos Haya
        • Contact:
        • Principal Investigator:
          • Jose Manuel Gonzalez-Gomez, MD
      • Valencia, Spain, 46010
        • Recruiting
        • Hospital Clínico Universitario
        • Contact:
        • Principal Investigator:
          • Patricia Roselló-Millet, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Pediatric patients admitted to the PICU equipped with a femoral arterial catheter and a central venous catheter or who require advanced hemodinamic monitoring

Description

Inclusion Criteria:

  • Pediatric patients admitted to PICU
  • Patient equipped with a femoral arterial catheter and central venous catheter or who requires advanced hemodynamic monitoring
  • Parents consent

Exclusion Criteria:

  • Absolute

    • Patient with left to right cardiac shunts
    • Patient with extra-corporeal life support
    • Less than 4 Kg body weight
  • For passive leg raising procedure

    • Patient with head trauma or intracranial hypertension
    • Patient in prone position
    • Patient who may not tolerate supine or Trendelenburg position: ej. Glenn procedure
    • Patient with hip injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Hemodynamic instability
Hypotension and/or evidence of end-organ hypoperfusion
Hemodynamic stability

Normotension and end-organ normoperfusion along with

  • Vasopressor, vasodilator or inotropic therapy
  • Edema and/or evidence of hypervolemia
Hemodinamically "normal"

Normotension and end-organ normoperfusion along with

  • Non vasopressor, vasodilator or inotropic therapy
  • Normohydration state
  • Non Systemic Inflammatory Response Syndrome
  • Spontaneous breathing and PEEP, or CPAP, equal or less than 5 cm H2O

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Pedro de la Oliva, MD PhD., Hospital Universitario La Paz
  • Principal Investigator: Ignacio Sánchez-Díaz, MD PhD, Hospital Universitario 12 de Octubre de Madrid
  • Principal Investigator: Elena Alvarez-Rojas, MD, Hospital Universitario Ramón y Cajal de Madrid
  • Principal Investigator: Susana Jaraba-Caballero, MD, Hospital Universitario Reina Sofía de Córdoba
  • Principal Investigator: Patricia Roselló-Millet, MD, Hospital Clinico Universitario de Valencia
  • Principal Investigator: José Manuel González-Gómez, MD, Hospital Universitario Carlos Haya de Málaga
  • Principal Investigator: Ana Serrano-Gonzalez, MD PhD, Hospital Infantil Universitario del Niño Jesús
  • Principal Investigator: Eduardo Consuegra-Llapur, MD, Hospital Universitario Materno-Infantil de las Palmas de Gran Canaria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (ANTICIPATED)

August 1, 2010

Study Completion (ANTICIPATED)

September 1, 2010

Study Registration Dates

First Submitted

July 6, 2010

First Submitted That Met QC Criteria

July 6, 2010

First Posted (ESTIMATE)

July 7, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

July 7, 2010

Last Update Submitted That Met QC Criteria

July 6, 2010

Last Verified

June 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Subscribe